Related Experiment Video
Updated: Sep 23, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are
Yuji Takaoka1, Yutaka Endo, Susumu Yamanobe
1Molecular Simulation Group, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama-shi, 331-9530 Saitama, Japan. yuji.takaoka@po.rd.taisho.co.jp
Abstract:
The concept of drug-likeness, an important characteristic for any compound in a screening library, is nevertheless difficult to pin down. Based on our belief that this concept is implicit within the collective experience of working chemists, we devised a data set to capture an intuitive human understanding of both this characteristic and ease of synthesis, a second key characteristic. Five chemists assigned a pair of scores to each of 3980 diverse compounds, with the component scores of each pair corresponding to drug-likeness and ease of synthesis, respectively. Using this data set, we devised binary classifiers with an artificial neural network and a support vector machine. These models were found to efficiently eliminate compounds that are not drug-like and/or hard-to-synthesize derivatives, demonstrating the suitability of these models for use as compound acquisition filters.
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Dissolution: Requirements and Profile Comparison
Drug Product Performance: In Vitro–In Vivo Correlation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Molecular Models